Back to search
FDAFDA · Food and drugs·Recall number D-220-2013

Ciprofloxacin Tablets USP, 500 mg, 100-count bottle, Rx only, Manufactured for West-ward Pharmaceutical Corp., Eatowntown, NJ 07724 by Hikma Pharmaceuticals, Amman, Jordan, NDC 0143-9928-01

Published April 3, 2013 · Recall initiated: February 6, 2013

Summary

FDA records drug Class II recall D-220-2013, published April 3, 2013 and initiated February 6, 2013. Recalling firm: West-ward Pharmaceutical Corp.; Status: Terminated; Reported quantity: 7,136 units; Lot: Lot #: CB222A, Exp 06/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Substance(s): A complaint was received for a rubber-like material in a 500 mg Ciprofloxacin tablet.

What to do

Voluntary: Firm initiated · Letter

Get an email if CIPROFLOXACIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CIPROFLOXACIN
Manufacturer
West-ward Pharmaceutical Corp.
Distributor
GA, AR
Lot
Lot #: CB222A, Exp 06/16
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ciprofloxacin Tablets USP, 500 mg, 100-count bottle, Rx only, Manufactured for West-ward Pharmaceutical Corp., Eatowntown, NJ 07724 by Hikma Pharmaceuticals, Amman, Jordan, NDC 0143-9928-01 recalled?

Yes. FDA published recall D-220-2013 on April 3, 2013. Reported hazard: Presence of Foreign Substance(s): A complaint was received for a rubber-like material in a 500 mg Ciprofloxacin tablet.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CIPROFLOXACIN.